MiR-3142-induced adriamycin resistance occurs through the targeting of PTEN, which leads to downregulation of the PTEN protein and activation of the PI3K/Akt pathway in chronic myeloid leukemia (CML) cells [31]. Here, PTEN is linked to chronic myelogenous leukemia, BCR-ABL1 positive.